9966 — Alphamab Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Alphamab Oncology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,382	2,064	1,985	1,350	1,407
Net Total Accounts Receivable
Net Total Receivables	36.1	84.8	67.5	79.5	72.5
Total Inventory
Total Other Current Assets
Total Current Assets	2,444	2,199	2,117	1,495	1,559
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	379	406	545	621	578
Long Term Notes Receivable
Total Assets	2,855	2,640	2,705	2,118	2,137
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	201	330	637	385	267
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	429	366	835	560	465
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,426	2,273	1,870	1,558	1,672
Total Liabilities & Shareholders' Equity	2,855	2,640	2,705	2,118	2,137
Total Common Shares Outstanding